# Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF

> **NCT05016817** · PHASE1 · RECRUITING · sponsor: **The Foundation for Orthopaedics and Regenerative Medicine** · enrollment: 20 (estimated)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **BIOLOGICAL:** AlloRx

## Key facts

- **NCT ID:** NCT05016817
- **Lead sponsor:** The Foundation for Orthopaedics and Regenerative Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-03
- **Primary completion:** 2025-11
- **Final completion:** 2025-11
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05016817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05016817, "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05016817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*